Compare Aurora Cannabis Inc (ACB) vs Amazon.com Inc (AMZN) Price & Performance

Aurora Cannabis (ACB) trades at $2.71, down 4.58% on the day, with a bearish technical outlook. The company reported a net income of $1.59 million in 2025, a significant improvement from a $69 million loss in 2024, though 2026 guidance projects a net loss of $136 million. Revenue grew to $343.29 million in 2025, but faces headwinds from Canadian reimbursement pressures. Analyst consensus is mixed, with 21.43% buy, 57.14% hold, and 21.43% sell ratings.

The stock's low P/B of 0.47 suggests undervaluation, but negative profitability metrics and a projected reset year in 2027 pose risks. Investment appeal hinges on execution in high-margin international medical markets, though volatility and competitive pressures remain key concerns for shareholders.

Amazon (AMZN) trades at $243.61, down 0.23% on the day, with strong technical momentum showing a bullish moving average signal despite overbought RSI conditions. The company demonstrates robust fundamental performance with revenue growth from $638B in 2024 to $716.9B in 2025 and net income surging to $77.67B. Recent earnings beats and CEO Andy Jassy's optimistic outlook on AWS growth have fueled positive sentiment.

Amazon presents a compelling investment case with 88% analyst buy ratings and a $321.11 price target representing 32% upside. Key opportunities include AWS expansion and AI chip development, while risks involve intense retail competition and significant capital expenditures. The stock's current valuation at 31.6x P/E reflects growth expectations but requires sustained execution.